28.51MMarket Cap-7000P/E (TTM)
3.700High3.510Low38.46KVolume3.510Open3.590Pre Close140.06KTurnover0.82%Turnover RatioLossP/E (Static)7.83MShares5.59052wk High1.22P/B17.15MFloat Cap3.34052wk Low--Dividend TTM4.71MShs Float13.200Historical High--Div YieldTTM5.29%Amplitude1.000Historical Low3.641Avg Price1Lot Size
ImmuCell Stock Forum
ImmuCell Corporation (Nasdaq: ICCC), a key player in the animal health industry, has recently announced its preliminary, unaudited sales results for the first quarter of 2024, and the figures are nothing short of impressive. With a staggering 111% increase in sales compared to the same period in 2023, and a 42% increase from the last quarter of ...
No comment yet